IceCure Medical Terminates VP of Operations
Ticker: ICCM · Form: 6-K · Filed: Oct 17, 2025 · CIK: 1584371
Sentiment: neutral
Topics: personnel-change, termination, management
Related Tickers: ICCM
TL;DR
IceCure Medical is firing its VP of Ops, Galit Malik, effective Jan 15, 2026.
AI Summary
On October 16, 2025, IceCure Medical Ltd. notified Ms. Galit Malik, its Vice President of Operations and Services, that her employment will be terminated effective January 15, 2026. This decision was not due to any disagreement with Ms. Malik.
Why It Matters
This filing indicates a change in key personnel within IceCure Medical's operational leadership, which could impact the company's ongoing projects and strategic execution.
Risk Assessment
Risk Level: low — The filing is a standard notification of employment termination and does not indicate any financial distress or significant operational issues.
Key Players & Entities
- IceCure Medical Ltd. (company) — Company filing the report
- Galit Malik (person) — Vice President of Operations and Services whose employment is being terminated
- January 15, 2026 (date) — Effective date of employment termination
- October 16, 2025 (date) — Date the notice of termination was delivered
FAQ
What is the effective date of Ms. Galit Malik's employment termination?
Ms. Galit Malik's employment contract will be terminated as of January 15, 2026.
When did IceCure Medical Ltd. deliver the notice of termination to Ms. Malik?
The notice of termination was delivered on October 16, 2025.
What is Ms. Galit Malik's role at IceCure Medical Ltd.?
Ms. Galit Malik is the Company's Vice President of Operations and Services.
Is the termination of Ms. Malik's employment related to any disagreement?
No, the filing states that Ms. Malik's termination was not related to any disagreement.
What type of filing is this report from IceCure Medical Ltd.?
This is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 292 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-10-17 08:00:20
Filing Documents
- ea0261493-6k_icecure.htm (6-K) — 11KB
- 0001213900-25-099716.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ICECURE MEDICAL LTD. Date: October 17, 2025 By: /s/ Eyal Shamir Name: Eyal Shamir Title: Chief Executive Officer 2